The Wall Street gold rush in business method patents is now moving to biotech and biopharmaceuticals. This panel will explore biotech business method patents in the United States, Canada, Europe and Japan and provide an educated look into the future of those patents, including issues concerning time to grant, scope of claims, defenses to infringement and problems in licensing and enforcement.



Objectives:

Discuss whether there are business method patent opportunities in your technology space.

Outline the types of patents available in United States,, Canada, Japan and Europe.

Examine how business method patents could enhance a company's competitive mix and advance its business goals.